Ross E. Crabtree
Impact in
- Pharmacology top 5%
- Cannabis and Cannabinoid Research
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
- Toxicology top 5%
- Forensic Toxicology and Drug Analysis
Papers in
-
- Pituitary Gland Disorders and Treatments 4
- Growth Hormone and Insulin-like Growth Factors 4
-
- Pharmacogenetics and Drug Metabolism 3
- Cannabis and Cannabinoid Research 3
- Co-authors
- Louis Lemberger (10 shared papers)Howard Rowe (5 shared papers)John T. Callaghan (4 shared papers)Alan Rubin (6 shared papers)Stanley M. Chernish (3 shared papers)Frank P. Bymaster (1 shared paper)Jong S. Horng (1 shared paper)David T. Wong (1 shared paper)
- Journals
- Clinical Pharmacology & Therapeutics (6 papers)Journal of Pharmaceutical Sciences (2 papers)Life Sciences (2 papers)Science (2 papers)The Journal of Clinical Endocrinology & Metabolism (2 papers)
- Partner nations
- United States
In The Last Decade
Ross E. Crabtree
24 papers receiving 489 citations
Peers
Comparison fields: 5 of 91
- Pharmacology 260
- Toxicology 50
- Cellular and Molecular Neuroscience 119
- Endocrinology, Diabetes and Metabolism 102
- Pharmacology 52
Countries citing papers authored by Ross E. Crabtree
This map shows the geographic impact of Ross E. Crabtree's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross E. Crabtree with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross E. Crabtree more than expected).
Fields of papers citing papers by Ross E. Crabtree
This network shows the impact of papers produced by Ross E. Crabtree. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross E. Crabtree. The network helps show where Ross E. Crabtree may publish in the future.
Co-authors
The 25 scholars most cited alongside Ross E. Crabtree, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1972 | 103 | |
| 2 | 1978 | 88 | |
| 3 | 1979 | 59 | |
| 4 | 1987 | 40 | |
| 5 | 1979 | 39 | |
| 6 | 1980 | 34 | |
| 7 | 1977 | 33 | |
| 8 | 1973 | 25 | |
| 9 | 1974 | 23 | |
| 10 | 1990 | 17 | |
| 11 | 1975 | 16 | |
| 12 | 1974 | 14 | |
| 13 | 1981 | 13 | |
| 14 | 1975 | 12 | |
| 15 | 1984 | 6 | |
| 16 | 1961 | 5 | |
| 17 | 1973 | 5 | |
| 18 | 1979 | 5 | |
| 19 | 1958 | 4 | |
| 20 | 1978 | 4 |
About Ross E. Crabtree
Ross E. Crabtree is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology, Molecular Biology, Pharmacology and Pathology and Forensic Medicine, having authored 24 papers that have together received 554 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (4 papers), Growth Hormone and Insulin-like Growth Factors (4 papers), Alcohol Consumption and Health Effects (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Cannabis and Cannabinoid Research (3 papers), Metabolism and Genetic Disorders (2 papers), Analytical Methods in Pharmaceuticals (2 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). The work is most often cited by research in Pharmacology (260 citations), Toxicology (50 citations), Cellular and Molecular Neuroscience (119 citations), Endocrinology, Diabetes and Metabolism (102 citations) and Pharmacology (52 citations). Ross E. Crabtree has collaborated with scholars based in United States. Frequent co-authors include Louis Lemberger, Howard Rowe, John T. Callaghan, Alan Rubin, Stanley M. Chernish, Frank P. Bymaster, Jong S. Horng, David T. Wong, Bernard D. Rosenak and Rocco L. Brunelle. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Journal of Pharmaceutical Sciences, Life Sciences, Science and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.